BioDuro-Sundia Overview
- Year Founded
-
1996
- Status
-
Private
- Employees
-
3,000
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
3
- Investments
-
6
BioDuro-Sundia General Information
Description
Operator of a contract research development amd manufacturing organization (CRDMO) intended for commercial drug products. The company offers fully integrated services to support its efforts from target identification to commercial drug product manufacturing, enabling biotech and pharmaceutical partners to deliver their drugs to patients and improve their lives.
Contact Information
Website
www.bioduro.comCorporate Office
- 9601 Jeronimo Road
- Irvine, CA 92618
- United States
Corporate Office
- 9601 Jeronimo Road
- Irvine, CA 92618
- United States
BioDuro-Sundia Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
BioDuro-Sundia Comparisons
Industry
Financing
Details
BioDuro-Sundia Competitors (66)
One of BioDuro-Sundia’s 66 competitors is NextPharma, a Private Equity-Backed company based in London, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| NextPharma | Private Equity-Backed | London, United Kingdom | ||||
| North American Science Associates | Private Equity-Backed | Toledo, OH | ||||
| Theorem Clinical Research | Formerly PE-Backed | King of Prussia, PA | ||||
| Bend Bioscience (Formerly CoreRx) | Private Equity-Backed | Clearwater, FL | ||||
| Anthem Biosciences | Formerly PE-Backed | Bengaluru, India |
BioDuro-Sundia Patents
BioDuro-Sundia Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230167132-A1 | Forms and compositions of inhibitors of plasma kallikrein | Inactive | 17-Apr-2020 | ||
| US-11370803-B2 | Heteroaryl plasma kallikrein inhibitors | Active | 18-Sep-2019 | ||
| US-12065448-B2 | Heteroaryl plasma kallikrein inhibitors | Active | 18-Sep-2019 | ||
| US-20210079022-A1 | Heteroaryl plasma kallikrein inhibitors | Active | 18-Sep-2019 | ||
| US-20220298176-A1 | Heteroaryl plasma kallikrein inhibitors | Active | 18-Sep-2019 | C07D519/00 |
BioDuro-Sundia Signals
BioDuro-Sundia Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
BioDuro-Sundia Investments (6)
BioDuro-Sundia’s most recent deal was a Joint Venture with Joint Venture (Chunghwa Chemical Synthesis & Biotech Company / BioDuro-Sundia). The deal was made on 03-Mar-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Joint Venture (Chunghwa Chemical Synthesis & Biotech Company / BioDuro-Sundia) | 03-Mar-2026 | Joint Venture | Drug Discovery | ||
| Commercial Drug Product Manufacturing Facility ( 45,000 ft2 ) | 01-Jan-2022 | Buyout/LBO | Buildings and Property | ||
| BioDuro-Sundia (Commercial Drug Product Manufacturing Facility in Irvine, California) | 23-Aug-2021 | Buyout/LBO | Buildings and Property | ||
| Sundia MediTech | 24-Sep-2020 | Buyout/LBO | BPO/Outsource Services | ||
| Molecular Response | 05-Mar-2018 | Buyout/LBO | Biotechnology |
BioDuro-Sundia Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Molecular Response | San Diego, CA | 2010 |
BioDuro-Sundia FAQs
-
When was BioDuro-Sundia founded?
BioDuro-Sundia was founded in 1996.
-
Where is BioDuro-Sundia headquartered?
BioDuro-Sundia is headquartered in Irvine, CA.
-
What is the size of BioDuro-Sundia?
BioDuro-Sundia has 3,000 total employees.
-
What industry is BioDuro-Sundia in?
BioDuro-Sundia’s primary industry is BPO/Outsource Services.
-
Is BioDuro-Sundia a private or public company?
BioDuro-Sundia is a Private company.
-
What is BioDuro-Sundia’s current revenue?
The current revenue for BioDuro-Sundia is .
-
Who are BioDuro-Sundia’s investors?
Advent International and Bridgewest Group have invested in BioDuro-Sundia.
-
Who are BioDuro-Sundia’s competitors?
NextPharma, North American Science Associates, Theorem Clinical Research, Bend Bioscience (Formerly CoreRx), and Anthem Biosciences are some of the 66 competitors of BioDuro-Sundia.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process